TerrAscend (TSNDF) Inventory Average (2022 - 2026)
TerrAscend's (TSNDF) quarterly Inventory Average came in at $35.1 million in Q1 2026, down 18.86% year-on-year from $43.3 million in Q1 2025, and up 3.37% on a QoQ basis from $34.0 million in Q4 2025.
TerrAscend (TSNDF) Inventory Average (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Inventory Average data on file, last reported at $35.1 million in Q1 2026.
- On a quarterly basis, Inventory Average fell 18.86% year-over-year to $35.1 million in Q1 2026; TTM through Mar 2026 was $35.1 million, a 18.86% decrease from a year earlier, with the FY2025 full-year figure at $36.9 million, down 19.3% from the prior year.
- Inventory Average for Q1 2026 stood at $35.1 million, up from $34.0 million in the prior quarter.
- Over the last five years, Inventory Average for TSNDF reached as high as $59.2 million in Q2 2022 and fell as low as $34.0 million in Q4 2025.
- Historically, Inventory Average has averaged $47.4 million across 5 years, with a median of $50.1 million in 2022.
- Across the five-year window, Inventory Average rose 13.96% in 2023 and sank 32.3% in 2025, its largest moves.
- Year by year, Inventory Average stood at $47.9 million in 2022, then gained by 13.96% to $54.5 million in 2023, then fell by 16.49% to $45.5 million in 2024, then declined by 25.36% to $34.0 million in 2025, then rose by 3.37% to $35.1 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $35.1 million in Q1 2026, $34.0 million in Q4 2025, and $34.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 35.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.14 Mn |
| Dec 31, 2025 | 34.00 Mn |
| Sep 30, 2025 | 34.68 Mn |
| Jun 30, 2025 | 41.18 Mn |
| Mar 31, 2025 | 43.31 Mn |
| Dec 31, 2024 | 45.55 Mn |
| Sep 30, 2024 | 51.22 Mn |
| Jun 30, 2024 | 50.10 Mn |
| Mar 31, 2024 | 50.44 Mn |
| Dec 31, 2023 | 54.54 Mn |
| Sep 30, 2023 | 55.71 Mn |
| Jun 30, 2023 | 52.41 Mn |
| Mar 31, 2023 | 48.57 Mn |
| Dec 31, 2022 | 47.86 Mn |
| Sep 30, 2022 | 51.88 Mn |
| Jun 30, 2022 | 59.21 Mn |
| Mar 31, 2022 | 50.08 Mn |